Insud Pharma
Cinthya Anabhela Silva Acuña serves as the Global Clinical Quality Manager at Insud Pharma since April 2020, previously holding roles as a Clinical Quality Specialist and GCP Auditor. Cinthya's background includes experience as a Senior Clinical Research Associate at CATO SMS, managing Oncology clinical research projects in Spain, and tenure at IQVIA focused on early-phase Oncology studies for Eli Lilly & Company. Earlier career roles include a Junior Consulting Project at Teva Pharmaceuticals and several positions at Covance and Merck Sharp & Dohme, overseeing clinical trial compliance and regulatory affairs. Cinthya holds an MBA in International Management from ESCP Business School and various degrees in pharmacy, clinical trials management, and coaching, currently pursuing a Master's in Translational Medicine at Universidad Complutense de Madrid.
This person is not in any offices
Insud Pharma
5 followers
INSUD PHARMA operates across the entire pharmaceutical value chain, delivering specialized expertise and experience in scientific research, development, manufacturing, sales and marketing of a wide range of value-adding active pharmaceutical ingredients (APIs), finished dosage forms (FDFs) and branded pharmaceuticals, for human and animal health. While the main offices are located in Madrid, Lugano, Buenos Aires, INSUD PHARMA is acting worldwide, creating a broad and balanced manufacturing and commercial network across Europe, America, Asia and Africa, to address global opportunities and customers` needs in all major pharmaceutical markets. INSUD PHARMA's activity is organized in three synergistic business areas: Industrial (Chemo), Branded (Exeltis) and Biotech (mAbxience), with over 7,300 professionals in more than 50 countries, 18 state-of-the-art facilities, 15 specialized R&D centers, 12 commercial offices and more than 35 pharmaceutical affiliates, serving 1,150 customers in 96 countries around the world. INSUD PHARMA believes in innovation and sustainable development. Our commitment is to improve people`s health and quality of life, providing access to quality medicines at affordable prices, and to continuously expand our efforts and R&D investment to develop new and better therapies.